Clinical trial
A Randomized Controlled Trial to Evaluate the Efficacy and Safety of Pogejiuxin Decoction Combination of Conventional Treatment for Heart Failure With Preserved Ejection Fraction(HFpEF)
NCT06629246 is registered in ClinicalTrials.gov with Chongqing Traditional Chinese Medicine Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Trial to Evaluate the Efficacy and Safety of Pogejiuxin Decoction Combination of Conventional Treatment for Heart Failure With Preserved Ejection Fraction(HFpEF)
- Lead sponsor
- Chongqing Traditional Chinese Medicine Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 1, 2021
- Completion date
- September 17, 2023
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
heart failure, diastolic (hfpef)